Introduction of Electrophiles in 1-Hydroxypyrazole
J . Org. Chem., Vol. 64, No. 15, 1999 5369
30 mL of H2O gave a clear solution. Addition of Et2O (50 mL),
separation of the organic layer, extraction of the aqueous phase
five times with ether, drying of the combined organic phases
(MgSO4), filtration, and evaporation gave 4.88 g of a mixture
of 4-bromo-1-hydroxypyrazole (5), dibrominated 1-hydroxy-
pyrazole, and unchanged starting material 4 in the ratio 79:
13:8 (1H NMR). A single recrystallization from EtOAc-heptane
(1:6, ca. 35 mL) gave 3.33 g (69%) of 4-bromo-1-hydroxypyra-
zole (5), mp 133 °C: 1H NMR ((CD3)2CO) δ 11.6 (br s, 1H),
7.72 (d, J ) 1.1 Hz, 1H), 7.21 (d, J ) 1.1 Hz, 1H); 13C NMR
(0.73 mL, 11.7 mmol) as the electrophile. After stirring at -78
°C for 30 min, 33% dimethylamine in ethanol (6 mL) was
added in order to destroy excess methyl iodide, and the solution
was allowed to warm to room temperature. Addition of
saturated aqueous NH4Cl (10 mL), adjustment of pH to 2 using
2 M HCl followed by extraction five times with Et2O, drying
of the combined organic phases (MgSO4), filtration, and
evaporation of the filtrate in vacuo followed by FC (HOAc-
EtOAc-heptane 1:10:200 f 1:10:50) gave 234 mg (70%) of
5-(tert-butyldiphenylsilyl)-1-hydroxy-4-methylpyrazole (9c), mp
202-204 °C (EtOAc-heptane 1:4): Rf(HOAc-EtOAc-heptane
1
3
((CD3)2CO) δ 131.6 (dd, J C-3,H-3 ) 194.8, J C-3,H-5 ) 7.7 Hz,
C-3), 121.8 (dd, 1J C-5,H-5 ) 199.1, 3J C-5,H-3 ) 2.9 Hz, C-5), 88.9
1:10:100) 0.09; H NMR (CDCl3) δ 7.70-7.30 (m, 10 H), 6.91
1
2
2
(dd, J C-4,H-5 and J C-4,H-3 5.9 and 6.4 Hz, C-4). Anal. Calcd
for C3H3BrN2O: C, 22.11; H, 1.86; N, 17.19. Found: C, 22.02;
H, 1,84; N, 16.93.
(s, 1 H), 1.28 (s, 3 H), 1.26 (s, 9 H); 13C NMR (CDCl3) δ 135.9,
133.7, 131.8, 129.4, 128.2, 127.8, 123.6, 28.7, 18.9, 11.2. Anal.
Calcd for C20H24N2OSi: C, 71.39; H, 7.19; N, 8.32. Found: C,
71.29; H, 7.28; N, 8.24.
4-Br om o-1-[ter t-(bu tyld ip h en ylsilyl)oxy]p yr a zole (6).
To a solution of 4-bromo-1-hydroxypyrazole (5) (2.59 g, 15.9
mmol) and N-ethyldiisopropylamine (2.80 mL, 16.3 mmol) in
15 mL of CH2Cl2 at -20 °C was added dropwise tert-butyl-
diphenylsilyl chloride (4.20 mL, 16.3 mmol). Stirring was
continued at room temperature for 12 h. Removal of the CH2-
Cl2 afforded a solid that was extracted with ether (4 × 50 mL).
The combined ether phases were filtered and evaporated to
dryness. Extraction with 50 °C heptane (4 × 50 mL), filtration
through activated carbon, and removal of the heptane gave
6.40 g (100%) of 4-bromo-1-[tert-(butyldiphenylsilyl)oxy]pyra-
zole (6),31 mp 66-69 °C (EtOAc-heptane): 1H NMR (CDCl3)
δ 7.73-7.67 (m, 4H), 7.51-7.33 (m, 6H), 6.98 (d, J ) 1.05 Hz,
1H), 6.95 (d, J ) 1.05 Hz, 1H), 1.17 (s, 9H); 13C NMR (CDCl3)
δ 135.6 (d), 132.0 (d), 130.6 (d), 130.1 (s), 127.7 (d), 121.8 (d),
89.9 (s), 26.5 (q), 19.2 (s). Anal. Calcd for C19H21BrN2OSi: C,
56.86; H, 5.27; N, 6.98. Found: C, 57.11; H, 5.40; N, 6.67.
Rea r r a n gem en t of 4-Br om o-1-[ter t-(bu tyld ip h en ylsi-
lyl)oxy]p yr a zole (6) in to 4-Br om o-5-(ter t-bu tyld ip h en yl-
silyl)-1-h yd r oxyp yr a zole (9a ). Freshly prepared LDA (2.99
mmol) in 6 mL of THF was added dropwise during 2 min to a
solution of 4-bromo-1-(tert-butyldiphenylsilyloxy)pyrazole (6)
(610 mg, 1.52 mmol) in THF (15 mL) at -78 °C. Stirring was
continued at -78 °C for 10 min, and aquesous HCl (4 M, 10
mL) was added. The solution was allowed to warm to room
temperature and extracted five times with Et2O. Removal of
the solvent in vacuo and FC (HOAc-EtOAc-heptane 1:10:
100 f 1:10:50) gave 560 mg (91%) of 4-bromo-5-(tert-butyl-
diphenylsilyl)-1-hydroxypyrazole (9a ), mp 173-175 °C: Rf-
(HOAc-EtOAc-heptane 1:10:100) 0.13; 1H NMR (CDCl3) δ
7.7-7.3 (m, 10 H), 7.07 (s, 1 H), 1.28 (s, 9 H); 13C NMR (CDCl3)
δ 136.0, 133.9, 132.4, 130.0, 129.6, 127.7, 101.0, 28.5, 19.0.
Anal. Calcd for C19H21BrN2OSi: C, 56.86; H, 5.27; N, 6.98.
Found: C, 57.02; H, 5.38; N, 7.02.
5-(ter t-Bu t yld ip h en ylsilyl)-4-for m yl-1-h yd r oxyp yr a -
zole (9d ). The general method was used with DMF (0.54 mL,
7 mmol) as the electrophile. After stirring at -78 °C for 30
min, the solution was allowed to warm to 0 °C over 1 h and
stirred for a further 1 h. Addition of 2 M HCl (10 mL), stirring
at room temperature for 1 h, separation of the organic phase,
extraction of the aqueous phase with CH2Cl2, drying of the
combined organic phases (MgSO4), filtration, and evaporation
of the filtrate in vacuo followed by FC (EtOAc-heptane 1:4 f
1:1) gave 348 mg (99%) of 5-(tert-butyldiphenylsilyl)-4-formyl-
1-hydroxypyrazole (9d ), mp 190-191 °C (EtOAc-heptane
1:4): Rf(EtOAc-heptane 1:1) 0.34; 1H NMR (CDCl3) δ 8.50 (s,
1 H), 7.71 (s, 1 H), 7.60-7.34 (m, 10 H), 1.31 (s, 9 H); 13C NMR
(CDCl3) δ 186.0, 136.0, 135.7, 134.1, 132.1, 130.3, 128.6, 128.3,
28.7, 18.9. Anal. Calcd for C20H22N2O2Si: C, 68.54; H, 6.33;
N, 7.99. Found: C, 68.46; H, 6.35; N, 7.97.
5-(ter t-Bu tyld ip h en ylsilyl)-1-h yd r oxy-4-(m eth ylth io)-
p yr a zole (9e). Using the general procedure, with dimethyl
disulfide (0.68 mL, 7.6 mmol) as the electrophile and workup
as described for 1-hydroxy-4-methyl-5-(tert-butyldiphenylsilyl)-
pyrazole (9c) gave 364 mg (99%) of 5-(tert-butyldiphenylsilyl)-
1-hydroxy-4-(methylthio)pyrazole (9e), mp 133-135 °C (EtOAc-
heptane 1:4): Rf(HOAc-EtOAc-heptane 1:10:100) 0.11; 1H
NMR (CDCl3) δ 7.80-7.30 (m, 10 H), 6.97 (s, 1 H), 1.85 (s, 3
H), 1.27 (s, 9 H); 13C NMR (CDCl3) δ 136.0, 134.2, 133.1, 131.5,
129.4, 127.5, 121.2, 28.5, 19.5, 18.9. Anal. Calcd for C20H24N2-
OSSi: C, 65.18; H, 6.56; N; 7.60 Found: C, 65.43; H, 6.72; N,
7.65.
3,5-Bis(tr im eth ylsilyl)-4-br om o-1-h ydr oxypyr azole (12).
A freshly prepared solution of LDA (37.4 mmol) in 30 mL of
THF was added at -78 °C during 4 min to a solution of
4-bromo-1-hydroxypyrazole (5) (1.51 g, 9.29 mmol) and tri-
methylsilyl chloride (7.4 mL, 58 mmol) in 20 mL of THF. The
reaction mixture was stirred at -50 to -40 °C for 3.5 h,
quenched with 4 M HCl (20 mL), and allowed to warm to room
temperature. The aqueous phase was extracted five times with
Et2O, and the combined organic phases were washed with
brine and water, dried (MgSO4), filtered, and evaporated in
vacuo to give 2.82 g (99%) of 3,5-bis(trimethylsilyl)-4-bromo-
1-hydroxypyrazole (12), mp 157-159 °C (pentane): 1H NMR
(CDCl3) δ 0.43 (s, 9H), 0.35 (s, 9H); 13C NMR (CDCl3) δ 143.7
Rea r r a n gem en t of 4-Br om o-1-[ter t-(bu tyld ip h en ylsi-
lyl)oxy]p yr a zole (6) in to 4-Br om o-1-lith oxy-5-(ter t-bu -
tyld ip h en ylsilyl)p yr a zole (8) F ollow ed by Br om in e-
Lith iu m Exch a n ge a n d Rea ction w ith a n Electr op h ile.
Gen er a l. Freshly prepared LDA (2 mmol) in 4 mL of THF
was added dropwise during 2 min to a solution of 4-bromo-1-
(tert-butyldiphenylsilyloxy)pyrazole (6) (401 mg, 1.00 mmol)
in THF (8 mL) at -78 °C. Stirring was continued at -78 °C
for 10 min, 1.44 M t-BuLi in pentane (2.78 mL, 4 mmol) was
added over 1 min, and the mixture was stirred at -78 °C for
a further 3 min before addition of the electrophile.
(s), 132.2 (s), 106.2 (s), -0.8 (q), -1.1 (q). Anal. Calcd for C9H19
-
BrN2OSi2: C, 46.84; H, 7.86; N, 10.92. Found: C, 47.07; H,
7.77; N, 10.91.
Lith ia tion of 3,5-Bis(tr im eth ylsilyl)-4-br om o-1-h yd r ox-
yp yr a zole (12) F ollow ed by Rea ction w ith a n Electr o-
p h ile. Gen er a l. To a solution of 3,5-bis(trimethylsilyl)-4-
bromo-1-hydroxypyrazole (12) (307 mg, 1.0 mmol) in THF (10
mL) was added dropwise 1.6 M n-BuLi in hexanes (3.13 mL,
5.0 mmol) at -78 °C over 2 min. The dark yellow solution was
stirred at -78 °C for 5 min and at -50 °C for 30 min and then
cooled to -78 °C whereupon the electrophile was added.
3,5-Bis(tr im eth ylsilyl)-4-[2H]-1-h yd r oxyp yr a zole (13b).
The general method with D2O (1.2 mL, 60 mmol) as the
electrophile was used. After stirring at -78 °C for 5 min, the
reaction mixture was allowed to warm to room temperature
over 30 min. Addition of 2 M HCl (10 mL), separation of the
organic layer, extraction of the aqueous layer with CH2Cl2,
washing of the combined organic phases with water, drying
5-(ter t-Bu t yld ip h en ylsilyl)-4-[2H ]-1-h yd r oxyp yr a zole
(9b). The general method was used with monodeuteriometha-
nol (0.60 mL, 15 mmol) as the electrophile. After stirring at
-78 °C for 30 min, the solution was allowed to warm to 0 °C
over 10 min. Standard workup gave 314 mg (97%) of 5-(tert-
butyldiphenylsilyl)-4-[2H]-1-hydroxypyrazole (9b). The 1H NMR
spectrum was identical with the spectrum of 5-(tert-butyl-
diphenylsilyl)-1-hydroxypyrazole2 except that the signal for
H-4 at 6.18 ppm was absent, indicating quantitative deutera-
tion at the 4-position.
5-(ter t-Bu t yld ip h en ylsilyl)-1-h yd r oxy-4-m et h ylp yr a -
zole (9c). The general method was used with methyl iodide
(31) 6 partially desilylated upon attempted flash chromathography.